MedPath

Supervised Exercise-training in Children With Insulin Resistance or Healthy Metabolic Profile

Not Applicable
Completed
Conditions
Insulin Sensitivity
Metabolism Disorder
Obesity, Pediatric
Registration Number
NCT03003754
Lead Sponsor
Universidad Santo Tomas
Brief Summary

Despite exercise training decrease blood fasting glycemia in 'average' terms, there is a wide interindividual variability after exercise training explored mainly in adults but not in children. Thus, is yet unknown what baseline health status as well as the influence of what health variable may produce more/less non-responder (NR) prevalence (i.e., percentage of subjects who experienced a non-change/worsened response after training in some metabolic outcomes) after exercise training in school children.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Diagnosed of insulin resistance by one of three plasmatic glucose control: HOMA-IR ≥3.0,
  • Fasting insulin levels ≥15 µUI/dL or fasting glucose ≥100 and ≤126 mg/dL within the enrolment stage applied at school (i.e., ≤3 months),
  • Physical inactivity (volume of ≤60 min/day of moderate physical activity),
  • To be participating of regular practical physical education classes at school (i.e., 90 min/week),
  • Living only in urban areas.
Exclusion Criteria
  • Potential medical, musculoskeletal problems or a familial history of T2DM,
  • Ischemic disease,
  • Arrhythmia,
  • Asthma,
  • Utilization of drugs that modulate the metabolic and respiratory control.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change from Baseline in plasma homeostasis model assessment (HOMA-IR)Baseline and 6 weeks immediately after the interventions ends
Secondary Outcome Measures
NameTimeMethod
Change from Baseline in one maximum repetition strength test of shoulder press exerciseBaseline and 6 weeks immediately after the interventions ends
Change from Baseline in fat massBaseline and 6 weeks immediately after the interventions ends
Change from Baseline in fasting glucoseBaseline and 6 weeks immediately after the interventions ends
Change from Baseline in body massBaseline and 6 weeks immediately after the interventions ends
Change from Baseline in one maximum repetition strength test of leg-extension exerciseBaseline and 6 weeks immediately after the interventions ends
Change from Baseline in blood pressureBaseline and 6 weeks immediately after the interventions ends
Change from Baseline in one maximum repetition strength test of upper-row exerciseBaseline and 6 weeks immediately after the interventions ends
Change from Baseline in body mass indexBaseline and 6 weeks immediately after the interventions ends
Change from Baseline in waist circumferenceBaseline and 6 weeks immediately after the interventions ends
Change from Baseline in one maximum repetition strength test of biceps curl exerciseBaseline and 6 weeks immediately after the interventions ends
Change from Baseline in fasting insulinBaseline and 6 weeks immediately after the interventions ends

Trial Locations

Locations (1)

Robinson Ramírez-Vélez

🇨🇴

Bogota Distrito Especial, Cundinamarca, Colombia

Robinson Ramírez-Vélez
🇨🇴Bogota Distrito Especial, Cundinamarca, Colombia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.